• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-520a-3p 通过 PI3K/AKT/mTOR 信号通路抑制非小细胞肺癌细胞生长和转移。

MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.

机构信息

Department of Respiratory, Linyi People's Hospital, Linyi, China.

出版信息

Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2321-2327. doi: 10.26355/eurrev_201804_14822.

DOI:10.26355/eurrev_201804_14822
PMID:29762835
Abstract

OBJECTIVE

MicroRNAs are a class of small non-coding RNAs that be involved in the pathogenesis of non-small cell lung cancer (NSCLC). The purpose of this study was to evaluate the effects of miR-520a-3p in cell growth and metastasis.

MATERIALS AND METHODS

The mimics and inhibitor of miR-520a-3p were used to identify the effects of miR-520a-3p on cell proliferation and apoptosis using methylthiazol tetrazolium (MTT) assay and flow-cytometric method, respectively. Transwell assay was used to evaluate the cell migration and invasion. The protein expression levels related PI3K/AKT/mTOR signaling pathways were measured by Western blot.

RESULTS

The results showed that miR-520a-3p overexpression could significantly inhibit cell proliferation and induce apoptosis, suppress cell migration and invasion. MiR-520a-3p overexpression could markedly reduce the ratio of p-AKT/AKT, p-PI3K/PI3K and Bcl-2/Bax, the levels of mTOR, matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) compared with control. However, miR-520a-3p overexpression could increase caspase-3 expression compared with control group. After inhibited the expression of miR-520a-3p, the capacity of cell proliferation, migration and invasion were increased, cell apoptosis was inhibited compared with control group. The ratio of p-AKT/AKT, p-PI3K/PI3K and Bcl-2/Bax, the levels of mTOR, MMP-2 and MMP-9 were increased compared with control group.

CONCLUSIONS

Our study suggested that miR-520a-3p could suppress the NSCLC proliferation, migration and invasion through PI3K/AKT/mTOR signaling pathway.

摘要

目的

微小 RNA 是一类参与非小细胞肺癌(NSCLC)发病机制的小非编码 RNA。本研究旨在评估 miR-520a-3p 在细胞生长和转移中的作用。

材料与方法

使用 miR-520a-3p 的模拟物和抑制剂,通过噻唑蓝(MTT)检测法和流式细胞术分别鉴定 miR-520a-3p 对细胞增殖和凋亡的影响。采用 Transwell 测定法评估细胞迁移和侵袭。通过 Western blot 测定法测定与 PI3K/AKT/mTOR 信号通路相关的蛋白表达水平。

结果

结果表明,miR-520a-3p 过表达可显著抑制细胞增殖并诱导细胞凋亡,抑制细胞迁移和侵袭。miR-520a-3p 过表达可使 p-AKT/AKT、p-PI3K/PI3K 和 Bcl-2/Bax 的比值、mTOR、基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)的水平明显降低,与对照组相比。然而,miR-520a-3p 过表达可使 caspase-3 的表达水平高于对照组。抑制 miR-520a-3p 的表达后,与对照组相比,细胞增殖、迁移和侵袭的能力增加,细胞凋亡受到抑制。p-AKT/AKT、p-PI3K/PI3K 和 Bcl-2/Bax 的比值、mTOR、MMP-2 和 MMP-9 的水平升高,与对照组相比。

结论

本研究表明,miR-520a-3p 可通过 PI3K/AKT/mTOR 信号通路抑制 NSCLC 的增殖、迁移和侵袭。

相似文献

1
MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.微小 RNA-520a-3p 通过 PI3K/AKT/mTOR 信号通路抑制非小细胞肺癌细胞生长和转移。
Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2321-2327. doi: 10.26355/eurrev_201804_14822.
2
The microRNA-520a-3p inhibits invasion and metastasis by targeting NF-kappaB signaling pathway in non-small cell lung cancer.微小 RNA-520a-3p 通过靶向非小细胞肺癌中的 NF-κB 信号通路抑制侵袭和转移。
Clin Transl Oncol. 2022 Aug;24(8):1569-1579. doi: 10.1007/s12094-022-02797-9. Epub 2022 Mar 5.
3
Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.微小RNA-135a通过IGF-1/PI3K/Akt信号通路对非小细胞肺癌细胞增殖、迁移、侵袭、凋亡及肿瘤血管生成的影响
Cell Physiol Biochem. 2017;42(4):1431-1446. doi: 10.1159/000479207. Epub 2017 Jul 17.
4
Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.微小RNA-16对肝癌细胞增殖、侵袭和转移的抑制作用。
Int J Mol Med. 2015 Dec;36(6):1713-9. doi: 10.3892/ijmm.2015.2379. Epub 2015 Oct 16.
5
Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.沉默长链非编码RNA ROR通过抑制PI3K/Akt/mTOR信号通路提高非小细胞肺癌对顺铂的敏感性。
Tumour Biol. 2017 May;39(5):1010428317697568. doi: 10.1177/1010428317697568.
6
Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway.姜黄素通过上调 miR-206 和抑制 PI3K/AKT/mTOR 信号通路抑制非小细胞肺癌细胞的迁移和侵袭。
Acta Pharm. 2020 Sep 1;70(3):399-409. doi: 10.2478/acph-2020-0029.
7
LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.长链非编码 RNA SNHG16 通过海绵吸附 miR-520a-3p 调控 EphA2 表达促进非小细胞肺癌发展。
Thorac Cancer. 2020 Mar;11(3):603-611. doi: 10.1111/1759-7714.13304. Epub 2020 Jan 17.
8
MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.miR-320a-3p/ELF3 轴通过 PI3K/Akt 通路调节非小细胞肺癌细胞的转移和侵袭。
Gene. 2018 Sep 5;670:31-37. doi: 10.1016/j.gene.2018.05.100. Epub 2018 May 24.
9
MicroRNA-520a-3p suppresses non-small-cell lung carcinoma by inhibition of High Mobility Group Box 1 (HMGB1).微小 RNA-520a-3p 通过抑制高迁移率族蛋白 B1(HMGB1)抑制非小细胞肺癌。
Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):1700-1708. doi: 10.26355/eurrev_201803_14583.
10
Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.长链非编码 RNA ZEB1-AS1 下调通过 miR-342-3p/CUL4B 轴调控 PI3K/AKT/mTOR 信号通路抑制前列腺癌细胞增殖、迁移和侵袭。
Cancer Biother Radiopharm. 2020 Nov;35(9):661-672. doi: 10.1089/cbr.2019.3123. Epub 2020 Apr 9.

引用本文的文献

1
Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting.靶向肺癌中的PI3K/AKT/mTOR信号通路:作用机制与治疗靶点
Front Pharmacol. 2025 Feb 18;16:1516583. doi: 10.3389/fphar.2025.1516583. eCollection 2025.
2
Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulation.中医治疗慢性乙型肝炎:信号通路调控机制
Heliyon. 2024 Oct 12;10(20):e39176. doi: 10.1016/j.heliyon.2024.e39176. eCollection 2024 Oct 30.
3
Harnessing the Therapeutic Potential of Mesenchymal Stem Cells in Cancer Treatment.
利用间充质干细胞在癌症治疗中的治疗潜力。
Adv Pharm Bull. 2024 Oct;14(3):574-590. doi: 10.34172/apb.2024.052. Epub 2024 Jun 22.
4
Non-coding RNAs and exosomal non-coding RNAs in lung cancer: insights into their functions.肺癌中的非编码RNA和外泌体非编码RNA:对其功能的见解
Front Cell Dev Biol. 2024 May 27;12:1397788. doi: 10.3389/fcell.2024.1397788. eCollection 2024.
5
Circulating miR-16-5p, miR-92a-3p and miR-451a are biomarkers of lung cancer in Tunisian patients.循环 miR-16-5p、miR-92a-3p 和 miR-451a 是突尼斯肺癌患者的生物标志物。
BMC Cancer. 2024 Apr 4;24(1):417. doi: 10.1186/s12885-024-12181-1.
6
Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer.与PI3K/AKT信号通路相关的微小RNA在肺癌中的作用进展
Front Oncol. 2023 Dec 19;13:1279822. doi: 10.3389/fonc.2023.1279822. eCollection 2023.
7
Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer.微小RNA对非小细胞肺癌的调控作用及治疗潜力
Heliyon. 2023 Nov 14;9(11):e22080. doi: 10.1016/j.heliyon.2023.e22080. eCollection 2023 Nov.
8
Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products.天然产物对 AKT 通路靶向 miRNA 的调控在癌症细胞治疗中的作用。
Int J Mol Sci. 2023 Feb 12;24(4):3688. doi: 10.3390/ijms24043688.
9
The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer.免疫系统和分子细胞信号通路在肺癌发病机制和进展中的重要性。
Int J Mol Sci. 2023 Jan 12;24(2):1506. doi: 10.3390/ijms24021506.
10
Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC - A systematic review.免疫调节框架及微小RNA在非小细胞肺癌发病机制中的作用——一项系统综述
Front Oncol. 2022 Dec 21;12:1089320. doi: 10.3389/fonc.2022.1089320. eCollection 2022.